Maitake MD-Fraction Original Research Can Maitake MD-Fraction Aid Cancer Patients? Noriko Kodama, PhD, Kiyoshi Komuta, MD, PhD, and Hiroaki Nanba, PhD Abstract Animal Studies Maitake mushroom (Grifola frondosa) MD- C3H mice bearing MM-46 carcinoma fraction...
More
Maitake MD-Fraction Original Research Can Maitake MD-Fraction Aid Cancer Patients? Noriko Kodama, PhD, Kiyoshi Komuta, MD, PhD, and Hiroaki Nanba, PhD Abstract Animal Studies Maitake mushroom (Grifola frondosa) MD- C3H mice bearing MM-46 carcinoma fraction containing beta-1,6 glucan with beta- (breast tumor) were given either 0.5 mg/kg MD- 1,3 branched chains has previously exhibited fraction by intraperitoneal (i.p.) injection or 1.0 strong anticancer activity by increasing mg/kg MD-fraction by oral administration for 10 immune-competent cell activity.1,2 In this non- days. After day 20, solid tumors were extirpated random case series, a combination of MD- and weighed to determine the tumor growth inhi- fraction and whole maitake powder was bition ratio. Tumor regression of 75-85-percent investigated to determine its effectiveness for was observed. Treatment with the MD-fraction 22- to 57-year-old cancer patients in stages II- increased the activities of natural killer cells, cy- IV.
Less
